| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872192 | The Annals of Thoracic Surgery | 2015 | 6 Pages |
Abstract
There was no significant difference between waiting list survival of patients with LVAD support as BTT and post-transplant survival of recipients with marginal donor hearts. There could be clinical benefits for using LVAD support as BTT to allow time for better allocation of optimal donor hearts as opposed to transplantation with a marginal donor heart.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Erin M. MD, Mickey S. MEng, Jaimin R. MD, MPH, Mark S. MD, Allen MD,